Target intelligence / Profile preview

Host tissues and microenvironment

Molecular classification
Other
01

Overview

The host tissues and microenvironment represent the complex, multi-component milieu surrounding cells, consisting of the extracellular matrix (ECM), stromal cells (such as fibroblasts and immune cells), blood vessels, and a variety of signaling molecules like cytokines and growth factors (National Cancer Institute, 2023). Rather than being a single molecular target, it is a dynamic ecosystem that regulates cell behavior, survival, and migration through biochemical and mechanical cues (Nature Reviews Cancer, 2009). In diseases like cancer, the tumor microenvironment (TME) is often co-opted to support malignancy, promote angiogenesis, and suppress immune surveillance (Cancer Cell, 2012). Therapeutic strategies targeting this environment aim to reprogram the niche—for example, by inhibiting pro-angiogenic factors or blocking immune checkpoints—to restore normal function or enhance the efficacy of direct anti-tumor agents (Nature Medicine, 2013). However, the heterogeneity and complexity of the microenvironment pose significant challenges for drug development and precision medicine, often leading to off-target effects in healthy tissues (Nature, 2013).

Other names
Tissue microenvironmentCellular nicheExtracellular matrix and stromaTumor microenvironmentTME
02

Mechanism of action

Modulation of the extracellular matrix, inhibition of paracrine signaling (e.g., VEGF, TGF-beta), blockade of immune checkpoints, and alteration of the physical and chemical properties of the cellular niche (Nature Medicine, 2013).

03

Biological functions

Signal transductionImmune responseCell proliferationStructural supportHomeostasis
04

Disease associations

CancerInflammationInfectionFibrosisNeurodegenerative disease
05

Safety considerations

Systemic toxicity due to lack of specificityDisruption of normal tissue homeostasisImpaired wound healingAutoimmune-related adverse eventsDifficulty in drug penetration through dense stroma
06

Interacting drugs

Bevacizumab

5 more in the full profile.

07

Biomarkers

PD-L1 expressionVEGF levelsCollagen densityCancer-associated fibroblast (CAF) markersCytokine profiles

Beyond the preview

Go deeper on Host tissues and microenvironment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host tissues and microenvironment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call